Media

November 7, 2025 | Publication
AMP-ImmunoModulator (AIM) Therapy Controls Growth and Eradicates Syngeneic Solid Tumors
November 7, 2025 | Publication
AMPLIFY-7P Phase 2: T cell responses induced by lymph node-targeted amphiphile therapeutic cancer vaccine in patients with KRAS mutated pancreatic ductal adenocarcinoma
September 17, 2025 | Publication
AMPLIFY-7P Phase 2 Immunogenicity Data
November 7, 2024 | Publication
AMPLIFY-7P Phase 1a: Lymph node-targeted amphiphile therapeutic cancer vaccine in patients with high relapse risk KRAS mutated pancreatic ductal adenocarcinoma and colorectal cancer
June 1, 2024 | Publication
AMPLIFY-7P, a first in human safety and efficacy trial of adjuvant mKRAS-specific lymph node-targeted Amphiphile ELI-002 7P vaccine in minimal residual disease positive pancreatic and colorectal cancer patients (ASCO 2024 – Scientific Poster)
April 10, 2024 | In the News
Podcast: How Can a Treatment Become a Vaccine??? Dr. Peter DeMuth, Chief Scientific Officer at Elicio Therapeutics

NPR BIOTECH NATION: Dr. Peter DeMuth, Chief Scientific Officer of Elicio Therapeutics, discusses the revolutionary approach of detecting cancer at its earliest stages through circulating tumor DNA (ctDNA) tests. Highlighting their innovative treatment method, which aims to train the body’s immune cells to recognize and destroy cancer cells, the episode explores the potential transition from treatment to vaccine, offering hope for more effective and durable solutions.

April 10, 2024 | In the News
Early cancer vaccine data breathe new life into the field, but many questions remain: #AACR24

ENDPOINTS NEWS: Scientists have long dreamed of creating vaccine-like treatments that could teach the immune system to target tumors. After decades of false starts, that idea is finally getting closer to reality.

April 9, 2024 | Publication
AMP-peptide vaccination against multiple p53 mutant epitopes promotes lymph node delivery to generate potent, functional T cell immunity (AACR 2024 – Scientific Poster)
April 9, 2024 | Publication
AMP-peptide vaccination against mutant BRAF epitopes promotes lymph node delivery to generate potent, functional T cell immunity (AACR 2024 – Scientific Poster)
April 8, 2024 | Publication
Durable immunogenicity of ELI-002 2P in AMPLIFY-201: Lymph node targeted mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer (AACR 2024 – Scientific Poster)